Methods of contraception include oral contraceptive pills, implants, Injectable, patches, vaginal rings, Intra uterine devices, condoms, male and female sterilization, lactational amenorrhea methods, withdrawal and fertility awareness based methods. These methods have different mechanisms of action and effectiveness in preventing unintended pregnancy.
This report aims to provide a comprehensive presentation of the global market for Contraceptives, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Contraceptives. This report contains market size and forecasts of Contraceptives in global, including the following market information:
Global Contraceptives Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Contraceptives Market Sales, 2018-2023, 2024-2029, (M Units)
Global top five Contraceptives companies in 2022 (%)
The global Contraceptives market was valued at US$ 1967.2 million in 2022 and is projected to reach US$ 2321.3 million by 2029, at a CAGR of 2.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Europe is the largest Contraceptives market with about 44% market share. North America is follower, accounting for about 37% market share.
The key players are Bayer AG, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, Merck & Co., Inc, Actavis, Inc., Johnson & Johnson, Gedeon Richter, Novo Nordisk A/S, ZiZhu, Baijingyu, Huazhong, Sine etc. Top 3 companies occupied about 46% market share.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Contraceptives manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Contraceptives Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (M Units)
Global Contraceptives Market Segment Percentages, by Type, 2022 (%)
- Pills
- Injectable
- Condoms
- Vaginal Rings
- IUDs
- Subdermal Implants
- Others
Global Contraceptives Market, by End User, 2018-2023, 2024-2029 ($ Millions) & (M Units)
Global Contraceptives Market Segment Percentages, by End User, 2022 (%)
- 15-24 years
- 25-34 years
- 35-44 years
- Above 44 years
Global Contraceptives Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (M Units)
Global Contraceptives Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- - US
- - Canada
- - Mexico
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- - Nordic Countries
- - Benelux
- - Rest of Europe
- Asia
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Rest of Asia
- South America
- - Brazil
- - Argentina
- - Rest of South America
- Middle East & Africa
- - Turkey
- - Israel
- - Saudi Arabia
- - UAE
- - Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Contraceptives revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Contraceptives revenues share in global market, 2022 (%)
Key companies Contraceptives sales in global market, 2018-2023 (Estimated), (M Units)
Key companies Contraceptives sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Bayer AG
- Pfizer, Inc
- Teva Pharmaceutical Industries Ltd
- Merck & Co., Inc
- Actavis, Inc.
- Johnson & Johnson
- Gedeon Richter
- Novo Nordisk A/S
- ZiZhu
- Baijingyu
- Huazhong
- Sine
- Reckitt
- AbbVie
- Church & Dwight
- The Cooper Companies
- TherapeuticsMD
- Afaxys
- Mithra Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Contraceptives, market overview.
Chapter 2: Global Contraceptives market size in revenue and volume.
Chapter 3: Detailed analysis of Contraceptives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by end user, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Contraceptives in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Contraceptives capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
Contraceptives Market, Global Outlook and Forecast 2023-2029
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Contraceptives Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by End User
1.3 Global Contraceptives Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Contraceptives Overall Market Size
2.1 Global Contraceptives Market Size: 2022 VS 2029
2.2 Global Contraceptives Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Contraceptives Sales: 2018-2029
3 Company Landscape
3.1 Top Contraceptives Players in Global Market
3.2 Top Global Contraceptives Companies Ranked by Revenue
3.3 Global Contraceptives Revenue by Companies
3.4 Global Contraceptives Sales by Companies
3.5 Global Contraceptives Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Contraceptives Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Contraceptives Product Type
3.8 Tier 1, Tier 2 and Tier 3 Contraceptives Players in Global Market
3.8.1 List of Global Tier 1 Contraceptives Companies
3.8.2 List of Global Tier 2 and Tier 3 Contraceptives Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Contraceptives Market Size Markets, 2022 & 2029
4.1.2 Pills
4.1.3 Injectable
4.1.4 Condoms
4.1.5 Vaginal Rings
4.1.6 IUDs
4.1.7 Subdermal Implants
4.1.8 Others
4.2 By Type - Global Contraceptives Revenue & Forecasts
4.2.1 By Type - Global Contraceptives Revenue, 2018-2023
4.2.2 By Type - Global Contraceptives Revenue, 2024-2029
4.2.3 By Type - Global Contraceptives Revenue Market Share, 2018-2029
4.3 By Type - Global Contraceptives Sales & Forecasts
4.3.1 By Type - Global Contraceptives Sales, 2018-2023
4.3.2 By Type - Global Contraceptives Sales, 2024-2029
4.3.3 By Type - Global Contraceptives Sales Market Share, 2018-2029
4.4 By Type - Global Contraceptives Price (Manufacturers Selling Prices), 2018-2029
5 Sights by End User
5.1 Overview
5.1.1 By End User - Global Contraceptives Market Size, 2022 & 2029
5.1.2 15-24 years
5.1.3 25-34 years
5.1.4 35-44 years
5.1.5 Above 44 years
5.2 By End User - Global Contraceptives Revenue & Forecasts
5.2.1 By End User - Global Contraceptives Revenue, 2018-2023
5.2.2 By End User - Global Contraceptives Revenue, 2024-2029
5.2.3 By End User - Global Contraceptives Revenue Market Share, 2018-2029
5.3 By End User - Global Contraceptives Sales & Forecasts
5.3.1 By End User - Global Contraceptives Sales, 2018-2023
5.3.2 By End User - Global Contraceptives Sales, 2024-2029
5.3.3 By End User - Global Contraceptives Sales Market Share, 2018-2029
5.4 By End User - Global Contraceptives Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Contraceptives Market Size, 2022 & 2029
6.2 By Region - Global Contraceptives Revenue & Forecasts
6.2.1 By Region - Global Contraceptives Revenue, 2018-2023
6.2.2 By Region - Global Contraceptives Revenue, 2024-2029
6.2.3 By Region - Global Contraceptives Revenue Market Share, 2018-2029
6.3 By Region - Global Contraceptives Sales & Forecasts
6.3.1 By Region - Global Contraceptives Sales, 2018-2023
6.3.2 By Region - Global Contraceptives Sales, 2024-2029
6.3.3 By Region - Global Contraceptives Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Contraceptives Revenue, 2018-2029
6.4.2 By Country - North America Contraceptives Sales, 2018-2029
6.4.3 US Contraceptives Market Size, 2018-2029
6.4.4 Canada Contraceptives Market Size, 2018-2029
6.4.5 Mexico Contraceptives Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Contraceptives Revenue, 2018-2029
6.5.2 By Country - Europe Contraceptives Sales, 2018-2029
6.5.3 Germany Contraceptives Market Size, 2018-2029
6.5.4 France Contraceptives Market Size, 2018-2029
6.5.5 U.K. Contraceptives Market Size, 2018-2029
6.5.6 Italy Contraceptives Market Size, 2018-2029
6.5.7 Russia Contraceptives Market Size, 2018-2029
6.5.8 Nordic Countries Contraceptives Market Size, 2018-2029
6.5.9 Benelux Contraceptives Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Contraceptives Revenue, 2018-2029
6.6.2 By Region - Asia Contraceptives Sales, 2018-2029
6.6.3 China Contraceptives Market Size, 2018-2029
6.6.4 Japan Contraceptives Market Size, 2018-2029
6.6.5 South Korea Contraceptives Market Size, 2018-2029
6.6.6 Southeast Asia Contraceptives Market Size, 2018-2029
6.6.7 India Contraceptives Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Contraceptives Revenue, 2018-2029
6.7.2 By Country - South America Contraceptives Sales, 2018-2029
6.7.3 Brazil Contraceptives Market Size, 2018-2029
6.7.4 Argentina Contraceptives Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Contraceptives Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Contraceptives Sales, 2018-2029
6.8.3 Turkey Contraceptives Market Size, 2018-2029
6.8.4 Israel Contraceptives Market Size, 2018-2029
6.8.5 Saudi Arabia Contraceptives Market Size, 2018-2029
6.8.6 UAE Contraceptives Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Bayer AG
7.1.1 Bayer AG Company Summary
7.1.2 Bayer AG Business Overview
7.1.3 Bayer AG Contraceptives Major Product Offerings
7.1.4 Bayer AG Contraceptives Sales and Revenue in Global (2018-2023)
7.1.5 Bayer AG Key News & Latest Developments
7.2 Pfizer, Inc
7.2.1 Pfizer, Inc Company Summary
7.2.2 Pfizer, Inc Business Overview
7.2.3 Pfizer, Inc Contraceptives Major Product Offerings
7.2.4 Pfizer, Inc Contraceptives Sales and Revenue in Global (2018-2023)
7.2.5 Pfizer, Inc Key News & Latest Developments
7.3 Teva Pharmaceutical Industries Ltd
7.3.1 Teva Pharmaceutical Industries Ltd Company Summary
7.3.2 Teva Pharmaceutical Industries Ltd Business Overview
7.3.3 Teva Pharmaceutical Industries Ltd Contraceptives Major Product Offerings
7.3.4 Teva Pharmaceutical Industries Ltd Contraceptives Sales and Revenue in Global (2018-2023)
7.3.5 Teva Pharmaceutical Industries Ltd Key News & Latest Developments
7.4 Merck & Co., Inc
7.4.1 Merck & Co., Inc Company Summary
7.4.2 Merck & Co., Inc Business Overview
7.4.3 Merck & Co., Inc Contraceptives Major Product Offerings
7.4.4 Merck & Co., Inc Contraceptives Sales and Revenue in Global (2018-2023)
7.4.5 Merck & Co., Inc Key News & Latest Developments
7.5 Actavis, Inc.
7.5.1 Actavis, Inc. Company Summary
7.5.2 Actavis, Inc. Business Overview
7.5.3 Actavis, Inc. Contraceptives Major Product Offerings
7.5.4 Actavis, Inc. Contraceptives Sales and Revenue in Global (2018-2023)
7.5.5 Actavis, Inc. Key News & Latest Developments
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Contraceptives Major Product Offerings
7.6.4 Johnson & Johnson Contraceptives Sales and Revenue in Global (2018-2023)
7.6.5 Johnson & Johnson Key News & Latest Developments
7.7 Gedeon Richter
7.7.1 Gedeon Richter Company Summary
7.7.2 Gedeon Richter Business Overview
7.7.3 Gedeon Richter Contraceptives Major Product Offerings
7.7.4 Gedeon Richter Contraceptives Sales and Revenue in Global (2018-2023)
7.7.5 Gedeon Richter Key News & Latest Developments
7.8 Novo Nordisk A/S
7.8.1 Novo Nordisk A/S Company Summary
7.8.2 Novo Nordisk A/S Business Overview
7.8.3 Novo Nordisk A/S Contraceptives Major Product Offerings
7.8.4 Novo Nordisk A/S Contraceptives Sales and Revenue in Global (2018-2023)
7.8.5 Novo Nordisk A/S Key News & Latest Developments
7.9 ZiZhu
7.9.1 ZiZhu Company Summary
7.9.2 ZiZhu Business Overview
7.9.3 ZiZhu Contraceptives Major Product Offerings
7.9.4 ZiZhu Contraceptives Sales and Revenue in Global (2018-2023)
7.9.5 ZiZhu Key News & Latest Developments
7.10 Baijingyu
7.10.1 Baijingyu Company Summary
7.10.2 Baijingyu Business Overview
7.10.3 Baijingyu Contraceptives Major Product Offerings
7.10.4 Baijingyu Contraceptives Sales and Revenue in Global (2018-2023)
7.10.5 Baijingyu Key News & Latest Developments
7.11 Huazhong
7.11.1 Huazhong Company Summary
7.11.2 Huazhong Contraceptives Business Overview
7.11.3 Huazhong Contraceptives Major Product Offerings
7.11.4 Huazhong Contraceptives Sales and Revenue in Global (2018-2023)
7.11.5 Huazhong Key News & Latest Developments
7.12 Sine
7.12.1 Sine Company Summary
7.12.2 Sine Contraceptives Business Overview
7.12.3 Sine Contraceptives Major Product Offerings
7.12.4 Sine Contraceptives Sales and Revenue in Global (2018-2023)
7.12.5 Sine Key News & Latest Developments
7.13 Reckitt
7.13.1 Reckitt Company Summary
7.13.2 Reckitt Contraceptives Business Overview
7.13.3 Reckitt Contraceptives Major Product Offerings
7.13.4 Reckitt Contraceptives Sales and Revenue in Global (2018-2023)
7.13.5 Reckitt Key News & Latest Developments
7.14 AbbVie
7.14.1 AbbVie Company Summary
7.14.2 AbbVie Business Overview
7.14.3 AbbVie Contraceptives Major Product Offerings
7.14.4 AbbVie Contraceptives Sales and Revenue in Global (2018-2023)
7.14.5 AbbVie Key News & Latest Developments
7.15 Church & Dwight
7.15.1 Church & Dwight Company Summary
7.15.2 Church & Dwight Business Overview
7.15.3 Church & Dwight Contraceptives Major Product Offerings
7.15.4 Church & Dwight Contraceptives Sales and Revenue in Global (2018-2023)
7.15.5 Church & Dwight Key News & Latest Developments
7.16 The Cooper Companies
7.16.1 The Cooper Companies Company Summary
7.16.2 The Cooper Companies Business Overview
7.16.3 The Cooper Companies Contraceptives Major Product Offerings
7.16.4 The Cooper Companies Contraceptives Sales and Revenue in Global (2018-2023)
7.16.5 The Cooper Companies Key News & Latest Developments
7.17 TherapeuticsMD
7.17.1 TherapeuticsMD Company Summary
7.17.2 TherapeuticsMD Business Overview
7.17.3 TherapeuticsMD Contraceptives Major Product Offerings
7.17.4 TherapeuticsMD Contraceptives Sales and Revenue in Global (2018-2023)
7.17.5 TherapeuticsMD Key News & Latest Developments
7.18 Afaxys
7.18.1 Afaxys Company Summary
7.18.2 Afaxys Business Overview
7.18.3 Afaxys Contraceptives Major Product Offerings
7.18.4 Afaxys Contraceptives Sales and Revenue in Global (2018-2023)
7.18.5 Afaxys Key News & Latest Developments
7.19 Mithra Pharmaceuticals
7.19.1 Mithra Pharmaceuticals Company Summary
7.19.2 Mithra Pharmaceuticals Business Overview
7.19.3 Mithra Pharmaceuticals Contraceptives Major Product Offerings
7.19.4 Mithra Pharmaceuticals Contraceptives Sales and Revenue in Global (2018-2023)
7.19.5 Mithra Pharmaceuticals Key News & Latest Developments
8 Global Contraceptives Production Capacity, Analysis
8.1 Global Contraceptives Production Capacity, 2018-2029
8.2 Contraceptives Production Capacity of Key Manufacturers in Global Market
8.3 Global Contraceptives Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Contraceptives Supply Chain Analysis
10.1 Contraceptives Industry Value Chain
10.2 Contraceptives Upstream Market
10.3 Contraceptives Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Contraceptives Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Contraceptives in Global Market
Table 2. Top Contraceptives Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Contraceptives Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Contraceptives Revenue Share by Companies, 2018-2023
Table 5. Global Contraceptives Sales by Companies, (M Units), 2018-2023
Table 6. Global Contraceptives Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Contraceptives Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Contraceptives Product Type
Table 9. List of Global Tier 1 Contraceptives Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Contraceptives Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type - Global Contraceptives Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Contraceptives Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Contraceptives Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Contraceptives Sales (M Units), 2018-2023
Table 15. By Type - Global Contraceptives Sales (M Units), 2024-2029
Table 16. By End User - Global Contraceptives Revenue, (US$, Mn), 2022 & 2029
Table 17. By End User - Global Contraceptives Revenue (US$, Mn), 2018-2023
Table 18. By End User - Global Contraceptives Revenue (US$, Mn), 2024-2029
Table 19. By End User - Global Contraceptives Sales (M Units), 2018-2023
Table 20. By End User - Global Contraceptives Sales (M Units), 2024-2029
Table 21. By Region - Global Contraceptives Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Contraceptives Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Contraceptives Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Contraceptives Sales (M Units), 2018-2023
Table 25. By Region - Global Contraceptives Sales (M Units), 2024-2029
Table 26. By Country - North America Contraceptives Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Contraceptives Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Contraceptives Sales, (M Units), 2018-2023
Table 29. By Country - North America Contraceptives Sales, (M Units), 2024-2029
Table 30. By Country - Europe Contraceptives Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Contraceptives Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Contraceptives Sales, (M Units), 2018-2023
Table 33. By Country - Europe Contraceptives Sales, (M Units), 2024-2029
Table 34. By Region - Asia Contraceptives Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Contraceptives Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Contraceptives Sales, (M Units), 2018-2023
Table 37. By Region - Asia Contraceptives Sales, (M Units), 2024-2029
Table 38. By Country - South America Contraceptives Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Contraceptives Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Contraceptives Sales, (M Units), 2018-2023
Table 41. By Country - South America Contraceptives Sales, (M Units), 2024-2029
Table 42. By Country - Middle East & Africa Contraceptives Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Contraceptives Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Contraceptives Sales, (M Units), 2018-2023
Table 45. By Country - Middle East & Africa Contraceptives Sales, (M Units), 2024-2029
Table 46. Bayer AG Company Summary
Table 47. Bayer AG Contraceptives Product Offerings
Table 48. Bayer AG Contraceptives Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Bayer AG Key News & Latest Developments
Table 50. Pfizer, Inc Company Summary
Table 51. Pfizer, Inc Contraceptives Product Offerings
Table 52. Pfizer, Inc Contraceptives Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Pfizer, Inc Key News & Latest Developments
Table 54. Teva Pharmaceutical Industries Ltd Company Summary
Table 55. Teva Pharmaceutical Industries Ltd Contraceptives Product Offerings
Table 56. Teva Pharmaceutical Industries Ltd Contraceptives Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Teva Pharmaceutical Industries Ltd Key News & Latest Developments
Table 58. Merck & Co., Inc Company Summary
Table 59. Merck & Co., Inc Contraceptives Product Offerings
Table 60. Merck & Co., Inc Contraceptives Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Merck & Co., Inc Key News & Latest Developments
Table 62. Actavis, Inc. Company Summary
Table 63. Actavis, Inc. Contraceptives Product Offerings
Table 64. Actavis, Inc. Contraceptives Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Actavis, Inc. Key News & Latest Developments
Table 66. Johnson & Johnson Company Summary
Table 67. Johnson & Johnson Contraceptives Product Offerings
Table 68. Johnson & Johnson Contraceptives Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Johnson & Johnson Key News & Latest Developments
Table 70. Gedeon Richter Company Summary
Table 71. Gedeon Richter Contraceptives Product Offerings
Table 72. Gedeon Richter Contraceptives Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Gedeon Richter Key News & Latest Developments
Table 74. Novo Nordisk A/S Company Summary
Table 75. Novo Nordisk A/S Contraceptives Product Offerings
Table 76. Novo Nordisk A/S Contraceptives Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Novo Nordisk A/S Key News & Latest Developments
Table 78. ZiZhu Company Summary
Table 79. ZiZhu Contraceptives Product Offerings
Table 80. ZiZhu Contraceptives Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. ZiZhu Key News & Latest Developments
Table 82. Baijingyu Company Summary
Table 83. Baijingyu Contraceptives Product Offerings
Table 84. Baijingyu Contraceptives Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Baijingyu Key News & Latest Developments
Table 86. Huazhong Company Summary
Table 87. Huazhong Contraceptives Product Offerings
Table 88. Huazhong Contraceptives Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. Huazhong Key News & Latest Developments
Table 90. Sine Company Summary
Table 91. Sine Contraceptives Product Offerings
Table 92. Sine Contraceptives Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. Sine Key News & Latest Developments
Table 94. Reckitt Company Summary
Table 95. Reckitt Contraceptives Product Offerings
Table 96. Reckitt Contraceptives Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 97. Reckitt Key News & Latest Developments
Table 98. AbbVie Company Summary
Table 99. AbbVie Contraceptives Product Offerings
Table 100. AbbVie Contraceptives Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 101. AbbVie Key News & Latest Developments
Table 102. Church & Dwight Company Summary
Table 103. Church & Dwight Contraceptives Product Offerings
Table 104. Church & Dwight Contraceptives Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 105. Church & Dwight Key News & Latest Developments
Table 106. The Cooper Companies Company Summary
Table 107. The Cooper Companies Contraceptives Product Offerings
Table 108. The Cooper Companies Contraceptives Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 109. The Cooper Companies Key News & Latest Developments
Table 110. TherapeuticsMD Company Summary
Table 111. TherapeuticsMD Contraceptives Product Offerings
Table 112. TherapeuticsMD Contraceptives Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 113. TherapeuticsMD Key News & Latest Developments
Table 114. Afaxys Company Summary
Table 115. Afaxys Contraceptives Product Offerings
Table 116. Afaxys Contraceptives Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 117. Afaxys Key News & Latest Developments
Table 118. Mithra Pharmaceuticals Company Summary
Table 119. Mithra Pharmaceuticals Contraceptives Product Offerings
Table 120. Mithra Pharmaceuticals Contraceptives Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 121. Mithra Pharmaceuticals Key News & Latest Developments
Table 122. Contraceptives Production Capacity (M Units) of Key Manufacturers in Global Market, 2021-2023 (M Units)
Table 123. Global Contraceptives Capacity Market Share of Key Manufacturers, 2021-2023
Table 124. Global Contraceptives Production by Region, 2018-2023 (M Units)
Table 125. Global Contraceptives Production by Region, 2024-2029 (M Units)
Table 126. Contraceptives Market Opportunities & Trends in Global Market
Table 127. Contraceptives Market Drivers in Global Market
Table 128. Contraceptives Market Restraints in Global Market
Table 129. Contraceptives Raw Materials
Table 130. Contraceptives Raw Materials Suppliers in Global Market
Table 131. Typical Contraceptives Downstream
Table 132. Contraceptives Downstream Clients in Global Market
Table 133. Contraceptives Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Contraceptives Segment by Type in 2022
Figure 2. Contraceptives Segment by End User in 2022
Figure 3. Global Contraceptives Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Contraceptives Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Contraceptives Revenue, 2018-2029 (US$, Mn)
Figure 7. Contraceptives Sales in Global Market: 2018-2029 (M Units)
Figure 8. The Top 3 and 5 Players Market Share by Contraceptives Revenue in 2022
Figure 9. By Type - Global Contraceptives Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Contraceptives Revenue Market Share, 2018-2029
Figure 11. By Type - Global Contraceptives Sales Market Share, 2018-2029
Figure 12. By Type - Global Contraceptives Price (USD/Unit), 2018-2029
Figure 13. By End User - Global Contraceptives Revenue, (US$, Mn), 2022 & 2029
Figure 14. By End User - Global Contraceptives Revenue Market Share, 2018-2029
Figure 15. By End User - Global Contraceptives Sales Market Share, 2018-2029
Figure 16. By End User - Global Contraceptives Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Contraceptives Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Contraceptives Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Contraceptives Revenue Market Share, 2018-2029
Figure 20. By Region - Global Contraceptives Sales Market Share, 2018-2029
Figure 21. By Country - North America Contraceptives Revenue Market Share, 2018-2029
Figure 22. By Country - North America Contraceptives Sales Market Share, 2018-2029
Figure 23. US Contraceptives Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Contraceptives Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Contraceptives Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Contraceptives Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Contraceptives Sales Market Share, 2018-2029
Figure 28. Germany Contraceptives Revenue, (US$, Mn), 2018-2029
Figure 29. France Contraceptives Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Contraceptives Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Contraceptives Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Contraceptives Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Contraceptives Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Contraceptives Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Contraceptives Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Contraceptives Sales Market Share, 2018-2029
Figure 37. China Contraceptives Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Contraceptives Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Contraceptives Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Contraceptives Revenue, (US$, Mn), 2018-2029
Figure 41. India Contraceptives Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Contraceptives Revenue Market Share, 2018-2029
Figure 43. By Country - South America Contraceptives Sales Market Share, 2018-2029
Figure 44. Brazil Contraceptives Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Contraceptives Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Contraceptives Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Contraceptives Sales Market Share, 2018-2029
Figure 48. Turkey Contraceptives Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Contraceptives Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Contraceptives Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Contraceptives Revenue, (US$, Mn), 2018-2029
Figure 52. Global Contraceptives Production Capacity (M Units), 2018-2029
Figure 53. The Percentage of Production Contraceptives by Region, 2022 VS 2029
Figure 54. Contraceptives Industry Value Chain
Figure 55. Marketing Channels
Global Drugs for Vulvovaginal Candidiasis Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 119
According to our LPI (LP Information) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at US$ 798.8 million in 2023. With growing demand in downstream market, the Drugs for Vulvovaginal Candidiasis is forecast to a readjusted size of US$ 890 million by 2030 with a CAGR of 1.6% during review period.
The research report highlights the growth potential of the global Drugs for Vulvovaginal Candidiasis market. Drugs for Vulvovaginal Candidiasis are expected t......
Global Bacterial Vaginosis Drug Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 132
According to our LPI (LP Information) latest study, the global Bacterial Vaginosis Drug market size was valued at US$ 896.6 million in 2023. With growing demand in downstream market, the Bacterial Vaginosis Drug is forecast to a readjusted size of US$ 1111.1 million by 2030 with a CAGR of 3.1% during review period.
The research report highlights the growth potential of the global Bacterial Vaginosis Drug market. Bacterial Vaginosis Drug are expected to show stable growth in the future ma......
Global Contraceptives Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 141
According to our LPI (LP Information) latest study, the global Contraceptives market size was valued at US$ 1870.3 million in 2023. With growing demand in downstream market, the Contraceptives is forecast to a readjusted size of US$ 2237.4 million by 2030 with a CAGR of 2.6% during review period.
The research report highlights the growth potential of the global Contraceptives market. Contraceptives are expected to show stable growth in the future market. However, product differentiation,......
Global Drugs for Vulvovaginal Candidiasis Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 108
According to our (Global Info Research) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at USD 840.2 million in 2023 and is forecast to a readjusted size of USD 928.4 million by 2030 with a CAGR of 1.4% during review period.
The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cu......
Global Menopausal Hot Flashes Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 28-Dec-2023 Price: US 3380 Onwards Pages: 99
Market Overview of Global Menopausal Hot Flashes market:
According to our latest research, the global Menopausal Hot Flashes market looks promising in the next 5 years. As of 2022, the global Menopausal Hot Flashes market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
Hot flashes during menopause are symptoms of menopause. They refer to the warmth that occurs during the transition period of ......
Global Bacterial Vaginosis Drug Market Research Report 2024 (Status and Outlook)
Published: 15-Dec-2023 Price: US 3200 Onwards Pages: 139
Report Overview:
This report studies the Bacterial Vaginosis Drug market, Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria. This report includes metronidazole, clindamycin drug and other drugs.
The Global Bacterial Vaginosis Drug Market Size was estimated at USD 916.50 million in 2022 and is projected to reach USD 1127.18 million by 202......
Global Drugs for Vulvovaginal Candidiasis Market Research Report 2024 (Status and Outlook)
Published: 15-Dec-2023 Price: US 3200 Onwards Pages: 122
Report Overview:
The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cure rates in excess of 80%. The only oral azole agent approved for this indication by the US Food and Drug Administration (FDA) is fluconazole, which also achieves a high cure rate. Therapeutic concentrations are found in vaginal secretions for a......
Global Bacterial Vaginosis Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 05-Dec-2023 Price: US 3380 Onwards Pages: 108
Market Overview of Global Bacterial Vaginosis Drug market:
According to our latest research, the global Bacterial Vaginosis Drug market looks promising in the next 5 years. As of 2022, the global Bacterial Vaginosis Drug market was estimated at USD 972.77 million, and it's anticipated to reach USD 1215.68 million in 2028, with a CAGR of 3.79% during the forecast years.
Bacterial vaginosis (BV), also known as bacterial vaginosis, non-specific vaginitis is a disease that occurs......
Global Tocolysis Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 30-Nov-2023 Price: US 3380 Onwards Pages: 123
Market Overview of Global Tocolysis Drugs market:
According to our latest research, the global Tocolysis Drugs market looks promising in the next 5 years. As of 2022, the global Tocolysis Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
Tocolytics are medications used to suppress premature labor. Tocolytic therapy is provided when delivery would result in premature birth, postponi......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
